Mostrando 3 resultados de: 3
Origen
scopus(3)
Consensus on diagnosis and management of Cushing's disease: a guideline update
ReviewAbstract: Cushing's disease requires accurate diagnosis, careful treatment selection, and long-term managementPalabras claves:Autores:Bancos I., Ben-Shlomo A., Bertherat J., Biermasz N.R., Biller B.M.K., Boguszewski C.L., Bronstein M.D., Buchfelder M., Carmichael J.D., Casanueva F.F., Castinetti F., Chanson P., Findling J.W., Fleseriu M., Gadelha M., Geer E.B., Giustina A., Grossman A., Gurnell M., Ho K., Ioachimescu A.G., Kaiser U.B., Karavitaki N., Katznelson L., Kelly D.F., Lacroix A., McCormack A.I., Melmed S., Molitch M., Mortini P., Newell-Price J., Nieman L.K., Pereira A.M., Petersenn S., Pivonello R., Raff H., Reincke M., Richard J. Auchus, Salvatori R., Scaroni C., Shimon I., Stratakis C.A., Swearingen B., Tabarin A., Takahashi Y., Theodoropoulou M., Tsagarakis S., Valassi E., Varlamov E.V., Vila G., Wass J., Webb S.M., Zatelli M.C.Fuentes:scopusEfficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
ArticleAbstract: Background: Cushing's disease is a rare endocrine disorder characterised by cortisol overproductionPalabras claves:Autores:Bertagna X., Biller B.M.K., Findling J.W., Fleseriu M., Gu F., Kim J.H., Lacroix A., Laplanche A., Lee E.J., Leelawattana R., Newell-Price J., O'Connell P., Pedroncelli A.M., Pivonello R., Richard J. Auchus, Shimatsu A., Tauchmanova L.Fuentes:scopusLong-term outcomes of osilodrostat in Cushing’s disease: LINC 3 study extension
ArticleAbstract: Objective: To investigate the long-term efficacy and tolerability of osilodrostat, a potent oral 11βPalabras claves:Autores:Belaya Z., Biller B.M.K., Feelders R.A., Fleseriu M., Houde G., Izquierdo M., Newell-Price J., Pedroncelli A.M., Pivonello R., Richard J. Auchus, Roughton M., Scaroni C., Shimatsu A., Vila G., Walia R.Fuentes:scopus